Alerts will be sent to your verified email
Verify Email
AMWILL
|
Amwill Health Care
|
Vaishali Pharma
|
Trident Lifeline
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
84.18 % | 7.61 % | 35.94 % |
|
5yr average Equity Multiplier
|
0.32 | 2.76 | 1.91 |
|
5yr Average Asset Turnover Ratio
|
2.35 | 0.89 | 0.9 |
|
5yr Avg Net Profit Margin
|
13.8 % | 3.52 % | 17.11 % |
|
Price to Book
|
1.72 | 2.56 | 6.05 |
|
P/E
|
11.08 | 202.8 | 29.6 |
|
5yr Avg Cash Conversion Cycle
|
115.9 Days | 133.52 Days | 94.4 Days |
|
Inventory Days
|
26.46 Days | 6.09 Days | 68.55 Days |
|
Days Receivable
|
133.46 Days | 217.95 Days | 104.41 Days |
|
Days Payable
|
129.03 Days | 174.07 Days | 126.58 Days |
|
5yr Average Interest Coverage Ratio
|
0.0 | 2.44 | 17.94 |
|
5yr Avg ROCE
|
102.76 % | 16.76 % | 29.15 % |
|
5yr Avg Operating Profit Margin
|
17.69 % | 6.18 % | 16.89 % |
|
5 yr average Debt to Equity
|
0.0 | 0.6 | 0.34 |
|
5yr CAGR Net Profit
|
33.09 % | 88.82 % | 9.93 % |
|
5yr Average Return on Assets
|
26.84 % | 3.1 % | 15.87 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
70.65 % | 26.32 % | 63.04 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 3.46 % |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | -0.42 % | -6.53 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Amwill Health Care
|
Vaishali Pharma
|
Trident Lifeline
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
-
|
Location Wise Break-Up
|